The impact of TP53 mutations and use of the TP53-mutation-reactivating agent APR-246 on metastatic castrate-sensitive prostate cancer.

被引：0
|
作者：
Hoang, Tung
Sutera, Philip
Nguyen, Triet
Chang, Jin Hee
Jagtap, Shreya
Song, Yang
Shetty, Amol
Chowdhury, Dipanwita
Chan, Aaron
Carrieri, Francesca Anna
Song, Daniel Y.
DeWeese, Theodore L.
Lafargue, Audrey
Van der Eecken, Kim
Ost, Fred Bunz Piet
Tran, Phuoc T.
Deek, Matthew
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Univ Maryland, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Sch Med, Baltimore, MD USA
[6] Ghent Univ Hosp, Ghent, Belgium
[7] Univ Ghent, Ghent, Belgium
[8] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17077
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Impact of TP53 Mutations and Use of the TP53Mutation-Reactivating Agent APR-246 on Metastatic Castrate-Sensitive Prostate Cancer
    Hoang, T.
    Sutera, P.
    Nguyen, T.
    Chang, J. H.
    Jagtap, S.
    Song, Y.
    Shetty, A.
    Chowdhury, D. D.
    Chan, A.
    Carrieri, F. A. A.
    Song, D.
    DeWeese, T. L.
    Lafargue, A.
    Van der Eecken, K.
    Bunz, F.
    Ost, P.
    Tran, P. T.
    Deek, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E443 - E443
  • [2] TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment
    Hoang, Tung
    Sutera, Philip
    Nguyen, Triet
    Chang, Jinhee
    Jagtap, Shreya
    Song, Yang
    Shetty, Amol C.
    Chowdhury, Dipanwita D.
    Chan, Aaron
    Carrieri, Francesca A.
    Hathout, Lara
    Ennis, Ronald
    Jabbour, Salma K.
    Parikh, Rahul
    Molitoris, Jason
    Song, Daniel Y.
    DeWeese, Theodore
    Marchionni, Luigi
    Ren, Lei
    Sawant, Amit
    Simone, Nicole
    Lafargue, Audrey
    Van Der Eecken, Kim
    Bunz, Fred
    Ost, Piet
    Tran, Phuoc T.
    Deek, Matthew P.
    PROSTATE, 2024, 84 (01): : 87 - 99
  • [3] Functional genetics of APR-246 rescuable TP53 mutants
    Saunders, Anais
    Tong, Caili
    Karnezis, Anthony N.
    Leiserowitz, Gary S.
    Chein, Jeremy R.
    CANCER RESEARCH, 2024, 84 (06)
  • [4] APR-246 cytotoxic effects are TP53 independent in endometrial cancer cell lines
    Yu, Camilla
    Petty, Aaron
    Vargas, Roberto
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
    Abrams, Stephen L.
    Duda, Przemyslaw
    Akula, Shaw M.
    Steelman, Linda S.
    Follo, Matilde L.
    Cocco, Lucio
    Ratti, Stefano
    Martelli, Alberto M.
    Montalto, Giuseppe
    Emma, Maria Rita
    Cervello, Melchiorre
    Rakus, Dariusz
    Gizak, Agnieszka
    McCubrey, James A.
    CELLS, 2022, 11 (05)
  • [6] Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
    Zhang, Wensheng
    Dong, Yan
    Sartor, Oliver
    Zhang, Kun
    CANCER INFORMATICS, 2022, 21
  • [7] Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
    Zhang, Wensheng
    Dong, Yan
    Sartor, Oliver
    Zhang, Kun
    CANCER INFORMATICS, 2022, 21
  • [8] Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
    Zhou, Jie
    Lai, Yiming
    Peng, Shengmeng
    Tang, Chen
    Chen, Yongming
    Li, Lingfeng
    Huang, Hai
    Guo, Zhenghui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status
    Fujihara, Kenji M.
    Benitez, Mariana Corrales
    Cabalag, Carlos S.
    Zhang, Bonnie Z.
    Ko, Hyun S.
    Liu, David S.
    Simpson, Kaylene J.
    Haupt, Ygal
    Lipton, Lara
    Haupt, Sue
    Phillips, Wayne A.
    Clemons, Nicholas J.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 1858 - 1867
  • [10] Analysis of TP53 gain of function mutations in metastatic castration-resistant prostate cancer.
    Sweeney, Patrick L.
    Lanka, Sree M.
    Jang, Albert
    Gupta, Kanika
    Caputo, Sydney
    Casado, Crystal
    Huang, Minqi
    Pocha, Olivia
    Hawkins, Maddie
    Lieberman, Alexandra
    Schwartz, Jennifer
    Jaeger, Ellen B.
    Miller, Patrick
    Barata, Pedro C.
    Layton, Jodi Lyn
    Lewis, Brian E.
    Ledet, Elisa M.
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345